Associação entre hipertensão gestacional (pré-eclâmpsia) e a covid-19: complicações maternas

• Autor(a) principal: Polo, Rafaela Oliveira
• Data de Publicação: 2022
• Tipo de documento: Trabalho de conclusão de curso
• Idioma: por
• Título da fonte: Biblioteca Digital de Monografias da UFMT
• Texto Completo: http://bdm.ufmt.br/handle/1/2487
• topic: CNPQ::CIENCIAS DA SAUDE::FARMACIA; Coronavírus; COVID-19; Grávidas; Hipertensão; Pré-Eclâmpsia; Pregnant ladies; COVID-19; Hypertension; Preeclamps

The new coronavirus pandemic was deemed an emergency health concern by the World Health Organization in March 2020. It was first identified as SARS-CoV-2, a virus that can cause Severe Acute Respiratory Syndrome, in Wuhan, China. Fever, exhaustion, coughing, and dyspnea are a few of the primary symptoms. Patients may also be asymptomatic or have mild to severe symptoms. Since it was possible to confirm that pregnant women with severe disease symptoms developed gestational complications like pre-eclampsia, eclampsia, premature births, gestational hypertension, and low birth weight of newborns, the obstetric population entered the priority groups in the treatment of the infection. In this study, coronavirus-infected pregnant women's scientific articles and their subsequent growth of preeclampsia. A literature review was conducted on articles between December 2021 and June 2022. It was discovered that the likelihood of developing maternal-fetal problems, such as preeclampsia, is correlated with the severity of SARS-CoV-2 infection. In contrast to gestational hypertension, a new illness called "PRE-ECLAMPSIA LIKE" with preeclampsialike symptoms has a clinical consequence as soon as the viral infection's symptoms go away, making termination of pregnancy the only course of action that could save the mother and fetus' lives.